DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.

The development of efficient vaccines against COVID-19 is an emergent need for global public health. The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major target for the COVID-19 vaccine. To quickly respond to the outbreak of the SARS-CoV-2 pandemic, a nucleic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kit Man Chai, Tsai-Teng Tzeng, Kuan-Yin Shen, Hung-Chun Liao, Jhe-Jhih Lin, Mei-Yu Chen, Guann-Yi Yu, Horng-Yunn Dou, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/ed966694d2fb48dfa78c64314db836a2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ed966694d2fb48dfa78c64314db836a2
record_format dspace
spelling oai:doaj.org-article:ed966694d2fb48dfa78c64314db836a22021-12-02T20:24:18ZDNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.1935-27271935-273510.1371/journal.pntd.0009374https://doaj.org/article/ed966694d2fb48dfa78c64314db836a22021-05-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009374https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735The development of efficient vaccines against COVID-19 is an emergent need for global public health. The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major target for the COVID-19 vaccine. To quickly respond to the outbreak of the SARS-CoV-2 pandemic, a nucleic acid-based vaccine is a novel option, beyond the traditional inactivated virus vaccine or recombinant protein vaccine. Here, we report a DNA vaccine containing the spike gene for delivery via electroporation. The spike genes of SARS-CoV and SARS-CoV-2 were codon optimized for mammalian cell expression and then cloned into mammalian cell expression vectors, called pSARS-S and pSARS2-S, respectively. Spike protein expression was confirmed by immunoblotting after transient expression in HEK293T cells. After immunization, sera were collected for antigen-specific antibody and neutralizing antibody titer analyses. We found that both pSARS-S and pSARS2-S immunization induced similar levels of antibodies against S2 of SARS-CoV-2. In contrast, only pSARS2-S immunization induced antibodies against the receptor-binding domain of SARS-CoV-2. We further found that pSARS2-S immunization, but not pSARS-S immunization, could induce very high titers of neutralizing antibodies against SARS-CoV-2. We further analyzed SARS-CoV-2 S protein-specific T cell responses and found that the immune responses were biased toward Th1. Importantly, pSARS2-S immunization in hamsters could induce protective immunity against SARS-CoV-2 challenge in vivo. These data suggest that DNA vaccination could be a promising approach for protecting against COVID-19.Kit Man ChaiTsai-Teng TzengKuan-Yin ShenHung-Chun LiaoJhe-Jhih LinMei-Yu ChenGuann-Yi YuHorng-Yunn DouChing-Len LiaoHsin-Wei ChenShih-Jen LiuPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 5, p e0009374 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Kit Man Chai
Tsai-Teng Tzeng
Kuan-Yin Shen
Hung-Chun Liao
Jhe-Jhih Lin
Mei-Yu Chen
Guann-Yi Yu
Horng-Yunn Dou
Ching-Len Liao
Hsin-Wei Chen
Shih-Jen Liu
DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
description The development of efficient vaccines against COVID-19 is an emergent need for global public health. The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major target for the COVID-19 vaccine. To quickly respond to the outbreak of the SARS-CoV-2 pandemic, a nucleic acid-based vaccine is a novel option, beyond the traditional inactivated virus vaccine or recombinant protein vaccine. Here, we report a DNA vaccine containing the spike gene for delivery via electroporation. The spike genes of SARS-CoV and SARS-CoV-2 were codon optimized for mammalian cell expression and then cloned into mammalian cell expression vectors, called pSARS-S and pSARS2-S, respectively. Spike protein expression was confirmed by immunoblotting after transient expression in HEK293T cells. After immunization, sera were collected for antigen-specific antibody and neutralizing antibody titer analyses. We found that both pSARS-S and pSARS2-S immunization induced similar levels of antibodies against S2 of SARS-CoV-2. In contrast, only pSARS2-S immunization induced antibodies against the receptor-binding domain of SARS-CoV-2. We further found that pSARS2-S immunization, but not pSARS-S immunization, could induce very high titers of neutralizing antibodies against SARS-CoV-2. We further analyzed SARS-CoV-2 S protein-specific T cell responses and found that the immune responses were biased toward Th1. Importantly, pSARS2-S immunization in hamsters could induce protective immunity against SARS-CoV-2 challenge in vivo. These data suggest that DNA vaccination could be a promising approach for protecting against COVID-19.
format article
author Kit Man Chai
Tsai-Teng Tzeng
Kuan-Yin Shen
Hung-Chun Liao
Jhe-Jhih Lin
Mei-Yu Chen
Guann-Yi Yu
Horng-Yunn Dou
Ching-Len Liao
Hsin-Wei Chen
Shih-Jen Liu
author_facet Kit Man Chai
Tsai-Teng Tzeng
Kuan-Yin Shen
Hung-Chun Liao
Jhe-Jhih Lin
Mei-Yu Chen
Guann-Yi Yu
Horng-Yunn Dou
Ching-Len Liao
Hsin-Wei Chen
Shih-Jen Liu
author_sort Kit Man Chai
title DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
title_short DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
title_full DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
title_fullStr DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
title_full_unstemmed DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
title_sort dna vaccination induced protective immunity against sars cov-2 infection in hamsterss.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/ed966694d2fb48dfa78c64314db836a2
work_keys_str_mv AT kitmanchai dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT tsaitengtzeng dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT kuanyinshen dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT hungchunliao dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT jhejhihlin dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT meiyuchen dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT guannyiyu dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT horngyunndou dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT chinglenliao dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT hsinweichen dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
AT shihjenliu dnavaccinationinducedprotectiveimmunityagainstsarscov2infectioninhamsterss
_version_ 1718374083067904000